Rasamsonia

• Previously known as Geosmithia and Penicillium species
• Causes invasive fungal infections in the lungs of immunocompromised patients, especially CGD and hematopoietic stem cell transplant patients
  • Can also cause disseminated disease
• May be treated with posaconazole, voriconazole, caspofungin, or combination therapy
  • Can be resistant to amphotericin B
• Mortality is about 40%